Global Information
회사소개 | 문의 | 위시리스트

세계의 피부과 의약품 시장 : 항생제, 항진균제, 항바이러스제

Dermatology Drugs Global Market Report 2019

리서치사 The Business Research Company
발행일 2019년 01월 상품 코드 531326
페이지 정보 영문 300 Pages
가격
US $ 4,000 ₩ 4,779,000 PDF by E-mail (Single User License)
US $ 6,000 ₩ 7,169,000 PDF by E-mail (Site License)
US $ 8,000 ₩ 9,559,000 PDF by E-mail (Enterprise License)


세계의 피부과 의약품 시장 : 항생제, 항진균제, 항바이러스제 Dermatology Drugs Global Market Report 2019
발행일 : 2019년 01월 페이지 정보 : 영문 300 Pages

세계의 피부과 의약품 시장을 조사했으며, 시장 정의와 개요, 시장에 대한 각종 영향요인 분석, 약제 부문·지역·국가별 동향과 시장 규모 추이 및 예측, 거시경제 요인·헬스케어 시장 전체·각종 산업 지표와의 비교, 경쟁 환경, 기업 개요 등을 정리하여 전해드립니다.

제1장 시장의 특징

제2장 시장 규모·성장률

  • 시장 성장 : 현재까지의 경위
    • 성장 촉진요인
    • 성장 억제요인
  • 시장 성장 : 예측
    • 성장 촉진요인
    • 성장 억제요인

제3장 PESTLE 분석

제4장 고객 정보

제5장 피부과 의약품 시장 분석 : 세분화별

  • 세계 시장의 실적 : 부문별
    • 항생제
    • 항진균제
    • 항바이러스제
  • 세계 시장의 추이와 예측 : 부문별
  • 시장 동향·전략

제6장 피부과 의약품 시장 분석 : 지역·국가별 분석

  • 세계 시장의 실적 : 지역별
  • 세계 시장의 추이와 예측 : 지역별
  • 시장 실적 : 국가별
  • 시장의 추이와 예측 : 국가별
  • 세계 의약품 시장의 실적 : 부문·지역별
  • 세계 의약품 시장의 실적 : 부문·국가별

제7장 거시경제 요인과 시장의 비교

  • 시장 규모의 GDP에서 차지하는 비율
  • 1인당 평균 지출액

제8장 거시경제 요인과 시장의 비교 : 국가별

  • 시장 규모의 GDP에서 차지하는 비율 : 국가별
  • 1인당 평균 지출액 : 국가별

제9장 산업 지표와 시장의 비교

  • 세계의 약제사 수 : 국가별
  • 시장 매출 vs 약제사 수 : 국가별
  • 세계의 의약품회사 수 : 국가별
  • 시장 매출 vs 의약품회사 수 : 국가별
  • 세계의 R&D/제품 개발에 대한 평균 지출액 : 국가별
  • 시장 매출 vs R&D/제품 개발에 대한 평균 지출액 : 국가별
  • 세계의 제네릭 & 브랜드 매출 비율 : 국가별
  • 시장 매출 vs 제네릭 & 브랜드 매출 비율 : 국가별
  • 피부염 환자 수 : 국가별

제10장 아시아태평양 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별
  • 국가별 분석
  • 중국
  • 인도
  • 일본
  • 호주

제11장 서유럽 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별
  • 국가별 분석
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인

제12장 동유럽 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별
  • 국가별 분석
  • 러시아

제13장 북미 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별
  • 국가별 분석
  • 미국

제14장 남미 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별
  • 국가별 분석
  • 브라질

제15장 중동 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별

제16장 아프리카 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별

제17장 경쟁 환경

  • 기업 개요
  • Galderma(Nestle Skin Health)
  • Johnson & Johnson
  • Abbvie
  • Glaxosmithkline
  • Pfizer

제18장 주요 M&A : 피부과 의약품 시장

제19장 시장 배경 : 의약품 시장

제20장 의약품 산업의 파이낸셜 마진

제21장 부록

KSA 17.08.07

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

Dermatology Drugs Market Global Report 2019 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global dermatology drugs market.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the dermatology drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Dermatology Drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The dermatology drugs market section of the report gives context. It compares the dermatology drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, dermatology drugs indicators comparison.

Scope

Markets Covered: Acne, Dermatitis, Psoriasis, Others

Companies Mentioned: Johnson & Johnson, Allergan Plc, Galderma S.A, Novartis AG, GlaxoSmithKline Plc

Metrics Covered: Number of Enterprises, Number of Employees

Countries: Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, dermatology drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Report Structure

3. Dermatology Drugs Market Characteristics

  • 3.1. Market Definition
  • 3.2. Key Segmentations

4. Dermatology Drugs Market Product Analysis

  • 4.1. Leading Products/ Services
  • 4.2. Key Features and Differentiators
  • 4.3. Development Products

5. Dermatology Drugs Market Supply Chain

  • 5.1. Supply Chain
  • 5.2. Distribution
  • 5.3. End Customers

6. Dermatology Drugs Market Customer Information

  • 6.1. Customer Preferences
  • 6.2. End Use Market Size and Growth

7. Dermatology Drugs Market Trends And Strategies

8. Dermatology Drugs Market Size And Growth

  • 8.1. Market Size
  • 8.2. Historic Market Growth, Value ($ Billion)
    • 8.2.1. Drivers Of The Market
    • 8.2.2. Restraints On The Market
  • 8.3. Forecast Market Growth, Value ($ Billion)
    • 8.3.1. Drivers Of The Market
    • 8.3.2. Restraints On The Market

9. Dermatology Drugs Market Regional Analysis

  • 9.1. Global Dermatology Drugs Market, 2018, By Region, Value ($ Billion)
  • 9.2. Global Dermatology Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • 9.3. Global Dermatology Drugs Market, Growth And Market Share Comparison, By Region

10. Dermatology Drugs Market Segmentation

  • 10.1. Global Dermatology Drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
    • 10.1.1. Acne
    • 10.1.2. Dermatitis
    • 10.1.3. Psoriasis
    • 10.1.4. Others

11. Dermatology Drugs Market Metrics

  • 11.1. Dermatology Drugs Market Size, Percentage Of GDP, 2014 - 2022, Global
  • 11.2. Per Capita Average Dermatology Drugs Market Expenditure, 2014 - 2022, Global

12. Asia-Pacific Dermatology Drugs Market

  • 12.1. Asia-Pacific Dermatology Drugs Market Overview
  • 12.2. Asia-Pacific, Dermatology Drugs Market, 2018, By Country, Value ($ Billion)
  • 12.3. Asia-Pacific, Dermatology Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 12.4. Asia-Pacific, Dermatology Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 12.5. Asia-Pacific, Dermatology Drugs Market Metrics
    • 12.5.1. Per Capita Average Dermatology Drugs Expenditure, 2014 - 2022, Asia-Pacific Countries
  • 12.6. Asia-Pacific Dermatology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 12.7. Asia-Pacific Dermatology Drugs Market: Country Analysis
    • 12.7.1. China Dermatology Drugs Market
      • 12.7.1.1. China Dermatology Drugs Market Overview
      • 12.7.1.2. China Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.1.3. China Dermatology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.1.4. China Dermatology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.2. Australia Dermatology Drugs Market
      • 12.7.2.1. Australia Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.2.2. Australia Dermatology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.2.3. Australia Dermatology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.3. Hong Kong Dermatology Drugs Market
      • 12.7.3.1. Hong Kong Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.4. India Dermatology Drugs Market
      • 12.7.4.1. India Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.4.2. India Dermatology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.4.3. India Dermatology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.5. Indonesia Dermatology Drugs Market
      • 12.7.5.1. Indonesia Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.6. Japan Dermatology Drugs Market
      • 12.7.6.1. Japan Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.6.2. Japan Dermatology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.6.3. Japan Dermatology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.7. Malaysia Dermatology Drugs Market
      • 12.7.7.1. Malaysia Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.8. New Zealand Dermatology Drugs Market
      • 12.7.8.1. New Zealand Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.9. Philippines Dermatology Drugs Market
      • 12.7.9.1. Philippines Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.10. Singapore Dermatology Drugs Market
      • 12.7.10.1. Singapore Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.11. South Korea Dermatology Drugs Market
      • 12.7.11.1. South Korea Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.12. Thailand Dermatology Drugs Market
      • 12.7.12.1. Thailand Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.13. Vietnam Dermatology Drugs Market
      • 12.7.13.1. Vietnam Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)

13. Western Europe Dermatology Drugs Market

  • 13.1. Western Europe Dermatology Drugs Market Overview
  • 13.2. Western Europe, Dermatology Drugs Market, 2018, By Country, Value ($ Billion)
  • 13.3. Western Europe, Dermatology Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 13.4. Western Europe, Dermatology Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 13.5. Western Europe, Dermatology Drugs Market Metrics
    • 13.5.1. Per Capita Average Dermatology Drugs Expenditure, 2014 - 2022, Western Europe Countries
  • 13.6. Western Europe Dermatology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 13.7. Western Europe Dermatology Drugs Market: Country Analysis
    • 13.7.1. Austria Dermatology Drugs Market
      • 13.7.1.1. Austria Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.2. Belgium Dermatology Drugs Market
      • 13.7.2.1. Belgium Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.3. Denmark Dermatology Drugs Market
      • 13.7.3.1. Denmark Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.4. Finland Dermatology Drugs Market
      • 13.7.4.1. Finland Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.5. France Dermatology Drugs Market
      • 13.7.5.1. France Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.5.2. France Dermatology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.5.3. France Dermatology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.6. Germany Dermatology Drugs Market
      • 13.7.6.1. Germany Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.6.2. Germany Dermatology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.6.3. Germany Dermatology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.7. Ireland Dermatology Drugs Market
      • 13.7.7.1. Ireland Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.8. Italy Dermatology Drugs Market
      • 13.7.8.1. Italy Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.8.2. Italy Dermatology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.8.3. Italy Dermatology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.9. Netherlands Dermatology Drugs Market
      • 13.7.9.1. Netherlands Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.10. Norway Dermatology Drugs Market
      • 13.7.10.1. Norway Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.11. Portugal Dermatology Drugs Market
      • 13.7.11.1. Portugal Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.12. Spain Dermatology Drugs Market
      • 13.7.12.1. Spain Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.12.2. Spain Dermatology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.12.3. Spain Dermatology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.13. Sweden Dermatology Drugs Market
      • 13.7.13.1. Sweden Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.14. Switzerland Dermatology Drugs Market
      • 13.7.14.1. Switzerland Dermatology Drugs Market2013 - 2022, Value ($ Billion)
    • 13.7.15. UK Dermatology Drugs Market
      • 13.7.15.1. UK Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.15.2. UK Dermatology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.15.3. UK Dermatology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

14. Eastern Europe Dermatology Drugs Market

  • 14.1. Eastern Europe Dermatology Drugs Market Overview
  • 14.2. Eastern Europe, Dermatology Drugs Market, 2018, By Country, Value ($ Billion)
  • 14.3. Eastern Europe, Dermatology Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 14.4. Eastern Europe, Dermatology Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 14.5. Eastern Europe, Dermatology Drugs Market Metrics
    • 14.5.1. Per Capita Average Dermatology Drugs Expenditure, 2014 - 2022, Eastern Europe Countries
  • 14.6. Eastern Europe Dermatology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 14.7. Eastern Europe Dermatology Drugs Market: Country Analysis
    • 14.7.1. Czech Republic Dermatology Drugs Market,
      • 14.7.1.1. Czech Republic Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 14.7.2. Poland Dermatology Drugs Market
      • 14.7.2.1. Poland Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 14.7.3. Romania Dermatology Drugs Market
      • 14.7.3.1. Romania Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 14.7.4. Russia Dermatology Drugs Market
      • 14.7.4.1. Russia Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 14.7.4.2. Russia Dermatology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 14.7.4.3. Russia Dermatology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

15. North America Dermatology Drugs Market

  • 15.1. North America Dermatology Drugs Market Overview
  • 15.2. North America, Dermatology Drugs Market, 2018, By Country, Value ($ Billion)
  • 15.3. North America, Dermatology Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 15.4. North America, Dermatology Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 15.5. North America, Dermatology Drugs Market Metrics
    • 15.5.1. Per Capita Average Dermatology Drugs Expenditure, 2014 - 2022, North America Countries
  • 15.6. North America Dermatology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 15.7. North America Dermatology Drugs Market: Country Analysis
    • 15.7.1. Canada Dermatology Drugs Market
      • 15.7.1.1. Canada Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 15.7.2. Mexico Dermatology Drugs Market
      • 15.7.2.1. Mexico Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 15.7.3. USA Dermatology Drugs Market
      • 15.7.3.1. USA Dermatology Drugs Market Overview
      • 15.7.3.2. USA Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 15.7.3.3. USA Dermatology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 15.7.3.4. USA Dermatology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

16. South America Dermatology Drugs Market

  • 16.1. South America Dermatology Drugs Market Overview
  • 16.2. South America, Dermatology Drugs Market, 2018, By Country, Value ($ Billion)
  • 16.3. South America, Dermatology Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 16.4. South America, Dermatology Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 16.5. South America, Dermatology Drugs Market Metrics
    • 16.5.1. Per Capita Average Dermatology Drugs Expenditure, 2014 - 2022, South America Countries
  • 16.6. South America Dermatology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 16.7. South America Dermatology Drugs Market: Country Analysis
    • 16.7.1. Argentina Dermatology Drugs Market
      • 16.7.1.1. Argentina Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.2. Brazil Dermatology Drugs Market
      • 16.7.2.1. Brazil Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 16.7.2.2. Brazil Dermatology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 16.7.2.3. Brazil Dermatology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 16.7.3. Chile Dermatology Drugs Market
      • 16.7.3.1. Chile Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.4. Colombia Dermatology Drugs Market
      • 16.7.4.1. Colombia Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.5. Peru Dermatology Drugs Market
      • 16.7.5.1. Peru Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.6. Venezuela Dermatology Drugs Market
      • 16.7.6.1. Venezuela Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)

17. Middle East Dermatology Drugs Market

  • 17.1. Middle East Dermatology Drugs Market Overview
  • 17.2. Middle East, Dermatology Drugs Market, 2018, By Country, Value ($ Billion)
  • 17.3. Middle East, Dermatology Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 17.4. Middle East, Dermatology Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 17.5. Middle East, Dermatology Drugs Market Metrics
    • 17.5.1. Per Capita Average Dermatology Drugs Expenditure, 2014 - 2022, Middle East Countries
  • 17.6. Middle East Dermatology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 17.7. Middle East Dermatology Drugs Market: Country Analysis
    • 17.7.1. Saudi Arabia Dermatology Drugs Market
      • 17.7.1.1. Saudi Arabia Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.7.2. Israel Dermatology Drugs Market
      • 17.7.2.1. Israel Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.7.3. Turkey Dermatology Drugs Market
      • 17.7.3.1. Turkey Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.7.4. UAE Dermatology Drugs Market
      • 17.7.4.1. UAE Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)

18. Africa Dermatology Drugs Market

  • 18.1. Africa Dermatology Drugs Market Overview
  • 18.2. Africa, Dermatology Drugs Market, 2018, By Country, Value ($ Billion)
  • 18.3. Africa, Dermatology Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 18.4. Africa, Dermatology Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 18.5. Africa, Dermatology Drugs Market Metrics
    • 18.5.1. Per Capita Average Dermatology Drugs Expenditure, 2014 - 2022, Africa Countries
  • 18.6. Africa Dermatology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 18.7. Africa Dermatology Drugs Market: Country Analysis
    • 18.7.1. Egypt Dermatology Drugs Market
      • 18.7.1.1. Egypt Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 18.7.2. Nigeria Dermatology Drugs Market
      • 18.7.2.1. Nigeria Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 18.7.3. South Africa Dermatology Drugs Market
      • 18.7.3.1. South Africa Dermatology Drugs Market, 2014 - 2022, Value ($ Billion)

19. Dermatology Drugs Market Competitive Landscape

  • 19.1. Competitive Market Overview
  • 19.2. Market Shares
  • 19.3. Company Profiles
    • 19.3.1. Johnson & Johnson
      • 19.3.1.1. Company Overview
      • 19.3.1.2. Company Dermatology Drugs Market Structure And Strategy
      • 19.3.1.3. Company Dermatology Drugs Market Products And Services
      • 19.3.1.4. Financial Performance
    • 19.3.2. Allergan Plc
      • 19.3.2.1. Company Overview
      • 19.3.2.2. Company Dermatology Drugs Market Structure And Strategy
      • 19.3.2.3. Company Dermatology Drugs Market Products And Services
      • 19.3.2.4. Financial Performance
    • 19.3.3. Galderma S.A
      • 19.3.3.1. Company Overview
      • 19.3.3.2. Company Dermatology Drugs Market Structure And Strategy
      • 19.3.3.3. Company Dermatology Drugs Market Products And Services
      • 19.3.3.4. Financial Performance
    • 19.3.4. Novartis AG
      • 19.3.4.1. Company Overview
      • 19.3.4.2. Company Dermatology Drugs Market Structure And Strategy
      • 19.3.4.3. Company Dermatology Drugs Market Products And Services
      • 19.3.4.4. Financial Performance
    • 19.3.5. GlaxoSmithKline Plc
      • 19.3.5.1. Company Overview
      • 19.3.5.2. Company Dermatology Drugs Market Structure And Strategy
      • 19.3.5.3. Company Dermatology Drugs Market Products And Services
      • 19.3.5.4. Financial Performance

20. Key Mergers And Acquisitions In The Dermatology Drugs Market

21. Market Background: Pharmaceutical Drugs Market

  • 21.1. Pharmaceutical Drugs Market Characteristics
  • 21.2. Pharmaceutical Drugs Market Historic and Forecast, 2014 - 2022 Growth, by segment, Value ($ Billion), Global
  • 21.3. Global Pharmaceutical Drugs Market, 2018, By Region, Value ($ Billion)
  • 21.4. Global Pharmaceutical Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • 21.5. Global Pharmaceutical Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

22. Recommendations

  • 22.1. Global Dermatology Drugs Market In 2022- Growth Countries
  • 22.2. Global Dermatology Drugs Market In 2022- Growth Segments
  • 22.3. Global Dermatology Drugs Market In 2022- Growth Strategies

23. Appendix

  • 23.1. NAICS Definitions Of Industry Covered In This Report
  • 23.2. Abbreviations
  • 23.3. Currencies
  • 23.4. Research Inquiries
  • 23.5. The Business Research Company

24. Copyright And Disclaimer

Back to Top
전화 문의
F A Q